20-46057189-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BS1_Supporting
The NM_020708.5(SLC12A5):c.3145C>T(p.Arg1049Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,186 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020708.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251288Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135890
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727234
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: SLC12A5 c.3214C>T (p.Arg1072Cys) results in a non-conservative amino acid change located in the SLC12A transporter, C-terminal domain (IPR018491) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 251288 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SLC12A5 causing Developmental And Epileptic Encephalopathy, 34, allowing no conclusion about variant significance. c.3214C>T has been reported in the literature in heterozygous state in individuals affected with idiopathic generalized epilepsy and autism spectrum disorder (examples: Kahle_2014 and Merner_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Developmental And Epileptic Encephalopathy, 34. At least one publication reports experimental evidence that this change affects SLC12A5 function, however, does not allow convincing conclusions about the variant effect in causing disease (Merner_2015). The following publications have been ascertained in the context of this evaluation (PMID: 24928908, 26528127). ClinVar contains an entry for this variant (Variation ID: 218378). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Epilepsy, idiopathic generalized, susceptibility to, 14;C4225257:Developmental and epileptic encephalopathy, 34 Uncertain:1
- -
Developmental and epileptic encephalopathy, 34 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1049 of the SLC12A5 protein (p.Arg1049Cys). This variant is present in population databases (rs548424453, gnomAD 0.02%). This missense change has been observed in individual(s) with SLC12A5-related conditions (PMID: 24928908, 26528127). ClinVar contains an entry for this variant (Variation ID: 218378). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects SLC12A5 function (PMID: 24928908). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Epilepsy, idiopathic generalized, susceptibility to, 14 Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at